M
Medix Infusion
Infusion therapy connecting chronically ill patients with compassionate care in underserved markets
About Medix Infusion
Medix Infusion is a healthcare startup that provides infusion therapy services to chronically ill and high-acuity patients, particularly in rural, suburban, and other under-served markets. The company operates in the healthcare sector, specifically in the area of infusion therapy, a treatment method where medication is delivered directly into the veins.
Medix Infusion's business model is centered around providing convenient and compassionate care. They have a team of experienced infusion and pharmacy veterans who ensure that patients have access to the necessary care. The company has developed an innovative and modern intake workflow process that includes insurance authorization, benefit verification, scheduling, patient communication, and home health coordination when needed.
The company operates both clinic suite locations and a home infusion service. Their clinics are equipped with comfortable recliners, iPads, and expert staff to ensure patient safety and ease of treatment. For patients unable to visit the clinics, Medix Infusion offers home infusion therapies, using the same intake and workflow processes to ensure patients receive their medication.
Medix Infusion's revenue is likely generated through service fees for the infusion therapies, which may be covered by patients' insurance. The company also operates a state-of-the-art home infusion pharmacy, which prepares and delivers medication therapy to patients' homes or to the clinics.
In summary, Medix Infusion is a healthcare startup providing infusion therapy services to under-served patients, with a focus on convenience and compassionate care.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jan 2023 | $7M | — | Live Oak Bank | ↗ |
| SERIES B✓Equity / VC | Jan 2023 | $28M | $112M | Echo Health Ventures · Pittco Management · Noro-Moseley Partners | ↗ |
Growth signals
Latest recorded traffic for Medix Infusion is 8.4K monthly website visits, down 10.6% over the last three months. Medix Infusion's team grew 8.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Echo Health Ventures
Pittco Management
Noro-Moseley Partners
Series B and later1 investor entered at this stage
Live Oak Bank
Other known investors1 additional known investor
Michael L. Sanderson
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medix Infusion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medix Infusion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







